|
|
Clinical effect of Reduning Injection in the treatment of sepsis-induced acute respiratory distress syndrome patients |
LI Wan-quan WU Shan QIU Chun-hui |
Department of Pharmacy, Shenzhen Traditional Chinese Medicine Hospital, Guangdong Province, Shenzhen 518000,China |
|
|
Abstract Objective To investigate the effect of Reduning Injection on the immune function of sepsis-induced acute respiratory distress syndrome patients, and the effect of Reduning Injection on the survival rate of sepsis-induced acute respiratory distress syndrome patients. Methods A total of 88 patients with sepsis-induced acute respiratory distress syndrome patients to our hospital from March 2018 to March 2019 were selected as the research objects, and they were divided into treatment group and reference group according to random number table method, 44 cases in each group.The patients in the reference group were treated with conventional Western medicine, and the patients in the treatment group were given Reduning Injection combined with conventional Western medicine treatment. During the treatment period, the immune function of the two groups of patients was observed, and the treatment efficacy and survival rate were statistically analyzed and evaluated. Results The CD3+, CD4+, CD4+/CD8+ of the patients in the treatment group were higher than those of the reference group, and the CD8+of the patients in the treatment group was lower than that of the reference group,the differences were statistically significant (P<0.05).The total effective rate in the treatment group was 90.91%, higher than that in the reference group of 68.18%, the difference was statistically significant (P<0.05); the survival rate of patients in the treatment group after 6 months of follow-up was 67.50% (27/40), the survival rate of the reference group 56.67% (17/30), the difference between the two groups was not statistically significant (P>0.05). Conclusion Reduning Injection has obvious clinical effect in treating patients with sepsis-induced acute respiratory distress syndrome, and it has an impact on the immune function of patients, which is worthy of clinical promotion and application.
|
|
|
|
|
[1] |
Walker E,Port G,Caparon M,et al.Glutathione Synthesis Contributes to Virulence of Streptococcus agalactiae in a Murine Model of Sepsis[J].J Bacteriol,2019,201(20):125-126.
|
[2] |
Hu P,Chen Y,Pa-ng J,et al.Association between IL-6 polymorphisms and sepsis[J].Innate immun,2019,25(8):569-568.
|
[3] |
杨乐,刘文明.如何看待IDSA 对2016《脓毒症和脓毒性休克的管理国际指南》的质疑[J].中华医院感染学杂志,2019,29(10):1591-1596.
|
[4] |
龚年金.中医辨证治疗急性肺损伤/急性呼吸窘迫综合征机械通气患者胃肠功能障碍疗效观察[J].现代中西医结合杂志,2017,26(15):1690-1692.
|
[5] |
邹蕾,黄志远,高燕,等.连续低效每日血液透析滤过联合血液灌流对严重脓毒症患者炎性应激和肾功能及微循环的影响[J].中国医药,2019,14(10):1543-1547.
|
[6] |
李新,崔巍,徐治波,等.乌司他丁治疗急性呼吸窘迫综合征的效果及其对血清炎性因子、血气指标的影响[J].疑难病杂志,2017,16(12):1225-1228,1232.
|
[7] |
李国臣,田正云,张飞虎,等.升降理肺汤治疗脓毒症相关性急性呼吸窘迫综合征的临床研究[J].中国中医急症,2019,28(8):1321-1323.
|
[8] |
陆佳燕.苏子降气汤配合热毒宁注射液治疗痰热阻肺型慢性阻塞性肺疾病疗效及对免疫功能的影响[J].现代中西医结合杂志,2019,28(26):2906-2909.
|
[9] |
朱卫华,侯红英,陈红.热毒宁注射液对重症肺炎患者血清炎症因子的影响[J].中国煤炭工业医学杂志,2019,22(3):296-299.
|
[10] |
黄威.热毒宁注射液联合头孢哌酮舒巴坦钠注射剂治疗COPD 伴有急性加重的疗效及对患者血清指标和肺功能的影响[J].内蒙古中医药,2019,38(10):55,157.
|
[11] |
党娇娇,吕健,孙梦华,等.热毒宁注射液治疗急性气管-支气管炎的系统评价与Meta 分析[J].中国中药杂志,2019,10(8):501.
|
[12] |
茹认派.热毒宁注射液与炎琥宁注射液治疗上呼吸道感染的效果比较[J].中国当代医药,2019,26(26):153-155.
|
[13] |
邢凯慧,王琦,宋依瑾,等.高频振荡通气联合肺表面活性剂治疗新生儿急性呼吸窘迫综合征的效果及对氧合功能的影响[J].中华实用诊断与治疗杂志,2019,33(9):895-898.
|
[14] |
谭志平,陈观尚,黄霞.热毒宁注射液联合纤维支气管肺泡灌洗吸痰对重症肺炎患者血T 淋巴细胞亚群及预后的影响[J].广州中医药大学学报,2019,36(10):1520-1526.
|
[15] |
周游,孙伏喜,吴伟,等.热毒宁注射液用于脓毒症致ARDS 患者效果观察[J].山东医药,2016,56(12):74-76.
|
[16] |
郑立斌.热毒宁注射液辅助治疗脓毒症初期患者的效果观察及其对炎性因子水平的影响[J].中国中医药科技,2019,26(2):172-175.
|
|
|
|